<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="107494">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01792063</url>
  </required_header>
  <id_info>
    <org_study_id>43430</org_study_id>
    <nct_id>NCT01792063</nct_id>
  </id_info>
  <brief_title>Two Different Preparations of Sevoflurane in Induction</brief_title>
  <official_title>A Randomized Clinical Trial on the Efficiency, Hemodynamic Effects and Patient Comfort of Two Different Preparations of Sevoflurane After Vital Capacity Rapid Inhalation Induction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istanbul University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istanbul University</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <authority>Turkey: Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In our study we aim to study the effects of  two preparations of Sevoflurane in vital
      capacity rapid inhalation induction.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Actual">April 2013</completion_date>
  <primary_completion_date type="Actual">April 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>effect of different preparations of sevoflurane on Induction on hypnosis time</measure>
    <time_frame>1 hour</time_frame>
    <safety_issue>No</safety_issue>
    <description>Induction for anesthesia will be achieved with sevoflurane A and Sevoflurane B in total of 100 randomized (American Society of Anesthesiology status I-II) patients undergoing abdominal surgery. During the induction patients will be asked to breath as deep as possible and then hold their breaths to the point where they cannot anymore and flexing their right arm. Occurrence of hypnosis will be confirmed with both the loss of eyelash-reflex and failing of flexed-holding arm. Time and number of breaths needed for the loss of consciousness will be noted. Existence of hiccup, cough, increase in secretions, and refusal of the mask by the patient will be reported if any. All patients will be extubated and released to the ward after they are questioned about any discomfort or issue they want to report to anesthesiologist</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>effect of different sevoflurane preparations on hemodynamics</measure>
    <time_frame>1 hour</time_frame>
    <safety_issue>No</safety_issue>
    <description>After the induction and occurrence of hypnosis, Systemic arterial pressure (SAP) values will be noted.  Tracheal intubation will be performed and post-intubation  SAP values will be noted. The SAP values will noted in the 5th minute of the induction.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Coughing on Induction</condition>
  <condition>Vapors; Inhalation</condition>
  <arm_group>
    <arm_group_label>Sevoflurane A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Generic sevoflurane</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sevoflurane B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Orginal sevoflurane</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <arm_group_label>Sevoflurane A</arm_group_label>
    <other_name>Sevorane, Abbott Laboratories</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <arm_group_label>Sevoflurane B</arm_group_label>
    <other_name>Sojourn, Adeka IS A.S</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing abdominal surgery

        Exclusion Criteria:

          -  Patients with any cardiovascular or respiratory disease, usage of any kind of
             sedative drug, expected airway difficulty and obese patients (BMI&gt;35) will be
             excluded from the study
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Cerrahpasa Medical Faculty Anesthesiology and Reanimation Department</name>
      <address>
        <city>Istanbul</city>
        <state>Fatih</state>
        <zip>34400</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Baker MT. Sevoflurane: are there differences in products? Anesth Analg. 2007 Jun;104(6):1447-51, table of contents. Review.</citation>
    <PMID>17513639</PMID>
  </reference>
  <verification_date>April 2013</verification_date>
  <lastchanged_date>April 18, 2013</lastchanged_date>
  <firstreceived_date>February 12, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istanbul University</investigator_affiliation>
    <investigator_full_name>Guniz M.Koksal</investigator_full_name>
    <investigator_title>Assoc.Prof</investigator_title>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Respiratory Aspiration</mesh_term>
    <mesh_term>Cough</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
